Back
Kenvue Vs. Viking Therapeutics Industry Stock Comparison
Sell
38
KVUE
Kenvue
Last Price:
22.96
Seasonality Move:
3.55%
Buy
66
VKTX
Viking Therapeutics
Last Price:
73.18
Seasonality Move:
23.93%
Sell
38
Kenvue (KVUE)
is a Sell
Is Kenvue a Buy, Sell or Hold?
- The current Kenvue [KVUE] share price is $22.97. The Score for KVUE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- KVUE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
66
Viking Therapeutics (VKTX)
is a Buy
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $73.22. The Score for VKTX is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- VKTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KVUE Stock Price Chart
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $73.22
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
KVUE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.07 | Buy |
| Relative Strength Index (14 RSI): | 61.55 | Buy |
| Chaikin Money Flow: | 2770474 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.8 - 23.08) | Buy |
| Bollinger Bands (100): | (18.56 - 22.54) | Buy |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.97 | Buy |
| Relative Strength Index (14 RSI): | 63.67 | Buy |
| Chaikin Money Flow: | 9568250 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (61.78 - 67.44) | Buy |
| Bollinger Bands (100): | (52.78 - 64.52) | Buy |
KVUE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.3 | Buy |
| 20-day SMA: | 22.3 | Buy |
| 50-day SMA: | 22.37 | Buy |
| 200-day SMA: | 20.27 | Buy |
| 8-day EMA: | 22.48 | Buy |
| 20-day EMA: | 22.35 | Buy |
| 50-day EMA: | 21.97 | Buy |
| 200-day EMA: | 21.03 | Buy |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 65.35 | Buy |
| 20-day SMA: | 64.33 | Buy |
| 50-day SMA: | 62.98 | Buy |
| 200-day SMA: | 58.03 | Buy |
| 8-day EMA: | 65.61 | Buy |
| 20-day EMA: | 64.61 | Buy |
| 50-day EMA: | 62.82 | Buy |
| 200-day EMA: | 54.1 | Buy |
Kenvue Earnings Growth & KVUE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and an increase next year of $0.09 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.45 per share.
Kenvue Technical Analysis
| Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||